Clearmind Medicine Inc

Company Profile

Clearmind Medicine Inc had its IPO on under the ticker symbol CMNDF.

The company operates in the sector and industry. Clearmind Medicine Inc has a staff strength of 0 employees.

Stock update

Shares of Clearmind Medicine Inc opened at $5 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.35 - $5, and closed at $4.61.

This is a -5.92% slip from the previous day's closing price.

A total volume of 65,343 shares were traded at the close of the day’s session.

In the last one week, shares of Clearmind Medicine Inc have increased by +41.41%.

Clearmind Medicine Inc's Key Ratios

Clearmind Medicine Inc has a market cap of $10.43 million, indicating a price to book ratio of 21.9792 and a price to sales ratio of 0.

In the last 12-months Clearmind Medicine Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-9374784. The EBITDA ratio measures Clearmind Medicine Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clearmind Medicine Inc’s operating margin was 0% while its return on assets stood at -141.25% with a return of equity of -275.49%.

In Q2.3333333333333, Clearmind Medicine Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Clearmind Medicine Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clearmind Medicine Inc’s profitability.

Clearmind Medicine Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.5648. Its price to sales ratio in the trailing 12-months stood at 0.

Clearmind Medicine Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.15 million

Total Liabilities

$783134.00

Operating Cash Flow

$-63399.00

Capital Expenditure

$0

Dividend Payout Ratio

0%

Clearmind Medicine Inc ended 2024 with $1.15 million in total assets and $0 in total liabilities. Its intangible assets were valued at $1.15 million while shareholder equity stood at $363366.00.

Clearmind Medicine Inc ended 2024 with $0 in deferred long-term liabilities, $783134.00 in other current liabilities, 9325606.00 in common stock, $-11728651.00 in retained earnings and $0 in goodwill. Its cash balance stood at $511420.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Clearmind Medicine Inc’s total current assets stands at $886558.00 while long-term investments were $0 and short-term investments were $306172.00. Its net receivables were $47790.00 compared to accounts payable of $602039.00 and inventory worth $0.

In 2024, Clearmind Medicine Inc's operating cash flow was $-63399.00 while its capital expenditure stood at $0.

Comparatively, Clearmind Medicine Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$4.61

52-Week High

$12

52-Week Low

$1.5

Analyst Target Price

$

Clearmind Medicine Inc stock is currently trading at $4.61 per share. It touched a 52-week high of $12 and a 52-week low of $12. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $4.74 and 200-day moving average was $6.89 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 254.9% of the company’s stock are held by insiders while 0% are held by institutions.